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Abstract
Substance-use disorders (SUDs) are a significant societal burden. Like many other con-
ditions, SUDs are characterized by chronic relapse after periods without symptoms. 
Alterations in synaptic plasticity have been documented after acute and addiction-related 
behavioral exposures to drugs of abuse. These synaptic alterations are persistent and 
similar to the chronic relapse state of patients with SUDs, suggesting that reversing these 
synaptic alterations may prevent relapse. Additionally, many of these synaptic features 
of addiction mirror those found in other forms of learning and memory. These features 
suggest that the etiology of this disorder stems from persistent modifications in corti-
colimbic synaptic plasticity mediated by drug-induced alterations in addiction-related 
gene (ARG) expression. Understanding the regulation of addiction-related genes and 
their impact on synaptic plasticity and behavior may inform new pharmacological treat-
ments that reverse these aberrant drug-evoked forms of plasticity in favor of remission.
Keywords: addiction, substance-use disorders, Fos, CREB, ADAR, BDNF, Mef2, miR-212, 
miR-9, FMRP, HuD, ELAVL
1. Introduction
Substance-use disorders (SUDs), or more colloquially known as drug addiction, are a sig-
nificant societal burden both financially, incurring an estimated $193 billion in costs (www.
justice.gov/ndic, 2011), and emotionally devastating to patients and their families. In opposi-
tion to more controlled, casual drug use, SUDs are characterized by uncontrollable bouts of 
drug consumption in spite of negative life consequences. Patients with this disorder appear to 
lose interest in normal prosocial activities, instead directing their energy toward the pursuit of 
these substances. Since addiction is a chronic, relapsing condition, this disorder has been noto-
riously difficult to manage. A complete review of pharmacological mechanisms of drugs of 
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abuse understanding of the molecular, physiological, and behavioral mechanisms involved in 
the disorder is necessary for the discovery and implementation of more effective treatments.
The mesolimbic dopamine system is the most well-studied and implicated circuit associ-
ated with the disorder. Naturally, this neurocircuit may have evolved as an information-
processing center to direct behavior toward environmentally important stimuli predicting 
the presence of vital resources, for example, food and water. Synaptic plasticity within these 
regions is implicated in associative learning of these stimuli to guide behavior necessary to 
receive these rewarding resources. Depending on the frequency and accuracy that a particu-
lar stimulus may predict a natural reward, goal-directed behavior toward this stimulus with 
the intention of obtaining the reward may become habitual. Thus, if an exogenous substance 
were to recruit this same neurocircuitry, this may elicit similar goal-directed behavior toward 
obtaining these compounds.
Structurally, drugs of abuse are highly varied and have many specific protein targets within 
the body (for a review of pharmacological mechanisms of drugs of abuse, see [1]). However, 
all pharmacological mechanisms of drugs of abuse cause excessive dopamine release origi-
nating from the ventral tegmental area within the nucleus accumbens (VTA, NAc; [2, 3]). 
Not only are these regions involved in this disorder, they also appear to be crucial mediators 
of appropriate goal-directed behavior toward natural rewards. Dopaminergic projections 
from VTA neurons are important in regulating motivation to perform integral, evolution-
arily conserved behaviors such as feeding and reproduction [4, 5]. Drug-elicited synaptic 
plasticity also occurs within this region, possibly through similar mechanisms as natural 
rewards. Mirroring a classical symptom of addiction, the synaptic alterations induced by 
drugs of abuse inhibit the ability of other non-drug-related experiences to elicit synaptic 
plasticity [6, 7]. As such, it has been hypothesized that drugs of abuse cause a heightened 
form of plasticity-dependent associative memory leading to habit formation and addiction-
like behaviors [8].
Although drug use is required for the development of addiction, it is most certainly not suf-
ficient to cause this disorder. For example, around 176.6 million Americans from the age of 
12 and up drink alcohol but only 17 million are classified as having an alcohol-use disorder 
(SAMSHA, 2013). Drugs are metabolized and eventually cleared from the body, thus, the 
drug’s pharmacological effect is not sufficient. In addition, SUDs are classically characterized 
by chronic relapse after periods without symptoms [9]. This may occur many years after a 
patient’s last reported use of a drug, suggesting that some stable functional  alteration has 
occurred within the brain. Repeated drug exposure is required for an accumulation of molec-
ular events that alter plasticity within specific regions affecting the functioning of the entire 
circuit. These synaptic alterations are persistent and similar to the chronic relapse state of 
patients with SUDs, suggesting that reversing these synaptic alterations may prevent relapse 
[9, 10]. Additionally, they appear to be protein-synthesis-dependent forms of plasticity [11–
13]. Thus, the molecular mechanisms regulating gene expression ending with the translation 
into functional protein may play a role in the etiology of this disorder and thus may stem 
from persistent modifications in region-specific synaptic plasticity mediated by drug-induced 
alterations in addiction-related gene (ARG) expression.
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Regulation of these molecules can occur at many different steps. The DNA in the genome is 
organized into small compact three-dimensional units assembled by histones into nucleo-
somes, which form the structure of chromatin. As such, basal transcription is necessarily stag-
nant in the absence of the regulation of gene accessibility. Modifications to the accessibility of 
genes, by regulation of these structures, are termed epigenetic regulation and have also been 
found to be an integral component in the development of addiction. Given that the epigenetic 
control of drug addiction has been elegantly reviewed in previous work [14–17], this chapter 
focuses on other aspects of gene expression control starting at the level of transcription.
2. Transcriptional regulation of addiction-related genes
Transcriptional regulation occurs through transcription factors, which are proteins that 
respond to intracellular changes leading to association with specific elements in target genes. 
Since the promoter region where the transcription factor binds to is outside of the coding 
region of that gene, these sequences are also termed cis-regulatory elements.
2.1. The Fos family transcription factors are differentially altered by drugs of abuse and 
contribute to addiction-related plasticity and behavior
Although altered transcription of various genes had been suggested by earlier work [18], 
it was not until the discovery that morphine caused increased striatal expression of a transcrip-
tion factor, c-Fos, that it was shown that transcription factors may regulate this drug-induced 
gene expression [19]. Although first found to be regulated by acute morphine treatment, 
it was found that other drugs of abuse cause specific, dopamine-dependent, alterations in the 
expression of this transcription factor within addiction-related regions [20–22]. Important for 
the study of relapse, it was found that c-Fos was upregulated in mesolimbic structures follow-
ing withdrawal, suggesting that it may play a role in the intense drug craving present in this 
disorder [23]. c-Fos is part of the Fos family of transcription factors, including FosB and ∆FosB, 
which all heterodimerize with Jun to form the AP-1 transcription factor complex [24]. This 
complex then associates its specific cyclic AMP response element (CRE), the AP-1  binding site, 
leading to increased transcription of genes downstream of these sequences.
Fos genes are considered immediate early genes (IEGs), or factors that are basally expressed 
at low levels but elevated rapidly by specific stimuli (first reviewed in the context of neu-
ronal cells [25]). Since it was upregulated by other plasticity and memory-inducing events, 
it was hypothesized that c-Fos, and possibly other IEGs, may alter gene expression involved 
in memory formation [26]. As expected, the upregulation of c-Fos, FosB, ∆FosB, and Jun leads 
to increased AP-1-mediated transcription within addiction-related regions such as the NAc 
rapidly after acute drug administration [27]. Due to its regional specificity, it was hypoth-
esized that alterations in these genes may provide a mechanism for reorganization of func-
tional interactions between these brain regions in addiction [28]. Although c-Fos is rapidly 
upregulated and returns to basal levels quickly, AP-1 binding continues in the absence of 
elevated c-Fos mRNA or protein expression suggesting that other Fos proteins may replace 
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c-Fos and  accumulate during chronic use of drugs. This may provide a molecular trace of 
chronic drug use in the absence of drug itself. This tolerance to initial c-Fos upregulation 
appears to be drug agnostic, as acute alcohol exposure blocked the previously observed acute 
cocaine upregulation of c-Fos, also suggesting that this molecular trace persists for the use of 
all different drugs [29].
To more specifically test the role of specific transcription factors in addiction, transgenic mice 
with specific mutations were engineered. The first experiment to utilize this approach used 
a transgenic mouse with a mutant fosB gene that prevented the production of ∆FosB. It is 
important to consider that this mutant fosB gene was not targeted to any specific cell type or 
even to the brain, but throughout the body. These mutant mice showed attenuated chronic 
induction of AP-1-binding activity, suggesting that the previously observed AP-1 binding 
without c-Fos upregulation was probably due to ∆FosB [30]. Additionally, this study was the 
first to link transcriptional regulation with altered addiction-like behavior. These researchers 
used a model of drug-seeking behavior termed conditioned place preference (CPP), where 
 animals are trained to associate one environment with an experimenter-administered drug 
and a  separate environment with saline [31]. Over time, animals will seek out the drug-paired 
cues associated with the environment where they received the drug. These fosB-mutant mice 
showed increased CPP compared to wild-type controls, suggesting that normal ∆FosB AP-1 
binding might be involved in a compensatory or adaptive response to drugs. Fos family mem-
bers have also been found to be upregulated after exposure to drug-paired cues in the absence 
of the drug itself, suggesting that this CPP effect may be due to the interaction between drug 
and cues soliciting the availability of the drug, an importance facet in addiction research [32].
Although certain molecular factors may cause increased addiction-like behavior or plasticity 
within one set of cells, it may cause an opposite effect on these measures in another. Cellular 
specificity is an important point that has been discussed in neuroscience for some time. In an 
experiment complimentary to this performed by Schroeder and colleagues, researchers devel-
oped an inducible system to specifically overexpress ∆FosB within D1 neurons in the stria-
tum [33]. Neurons within the striatum are primarily GABAergic medium-spiny neurons that 
mostly express D1 or D2 dopamine receptors. Since D1 receptors are G
s
 GPCRs, they activate 
the neuron leading to increased GABA release, while D2 receptors are G
i
 and are inhibited 
by dopamine binding. Since drugs of abuse cause hyperdopaminergic conditions within 
the striatum, both D1 and D2 containing neurons play important but dissociable roles in the 
development of addiction. Targeted ∆FosB overexpression in D1 neurons showed a similar 
effect on increased CPP behavior at low doses (5 and 15 mg/kg), but normal CPP behavior at 
higher doses (20 mg/kg). This suggests that cocaine-induced ∆FosB expression within these 
cells is necessary and sufficient to promote addiction-like behaviors. Furthermore, GABAergic 
inhibition from these cells may play a role in CPP behavior. Finally, this is physiologically 
 relevant, as drugs of abuse and to a lesser extent natural rewards cause upregulation of ∆FosB 
in this specific neuronal subtype [28, 34]. In a similar experiment, nonspecific deletion of ∆FosB 
throughout the body caused the same behavioral alteration, increased CPP behavior to lower 
doses of cocaine [30]. Although this finding may seem contradictory, when taken together 
with previous data, this points to the existence of other regions or possibly neuronal subtypes 
that act in opposition to D1 neurons. Following up on this, overexpression of ∆FosB within D2 
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expressing neurons in the striatum produced no effects, illustrating the cellular specificity of 
these drug-induced alterations [35]. Thus, ∆FosB within these regions or cells may not play a 
role, or possibly inhibit, the plasticity required for the development of these behaviors.
Another behavioral model frequently used to study addiction is self-administration of 
drugs [36]. In this model, an intravenous catheter will infuse cocaine into the animal once it 
has completed a specific behavioral response, usually pressing an active lever in opposition 
to an inactive lever that produces no effect. This can be used to study motivation to consume 
drugs, as the requirement for lever pressing can be made harder by increasing the number 
of presses required to receive an infusion of drug. Animals with a similar inducible ∆FosB 
genotype as used by Kelz and colleagues showed increased motivation to self-administer 
cocaine [37]. This was also the first experiment to show that this alteration specifically affected 
motivation toward drugs and not naturally rewards such as a food pellet.
Transcription factors elicit changes in the expression of genes; thus this work suggests that 
there must be some downstream targets of Fos proteins that are mediating these effects on 
addiction-related behavior. Kelz and colleagues first described a downstream target that may 
alter plasticity involved in these behavioral alterations [33]. Striatal neurons are normally 
quiescent, even with dopamine input, and thus require glutamate which is an important 
 neurotransmitter in addiction-like behaviors to alter their firing (reviewed in [38]). Kelz and 
colleagues found that ∆FosB overexpression caused an increase in a specific AMPAR subunit, 
GluR2 which could lead to altered plasticity [39]. Additionally, they could recapitulate their 
effects on behavior by viral-mediated overexpression of this subunit in the striatum. Overall, 
many ∆FosB targets are genes that appear to be previously linked to addiction-like behaviors 
such as CDK5 and NFkB.
2.2. CREB, a transcription factor well established in learning and memory associated 
plasticity, plays a role in addiction
Drugs of abuse can cause acute regulation of molecular-signaling cascades that can modify 
transcription factor activity. For example, many drugs of abuse can cause acute upregulation 
of the second messenger cAMP within many addiction-associated brain regions [40–46]. cAMP 
response element-binding protein (CREB) is phosphorylated in response to cAMP upregu-
lation by a kinase sensitive to cAMP, protein kinase A (PKA; [47, 48]),  calcium-calmodulin 
dependent kinases (CaMK) and other kinases [49]. The role of CREB in other forms of plastic-
ity-associated memory has been well elucidated [48]. Once phosphorylated, CREB can enter 
the nucleus and bind to its response element, the cyclic AMP response element (CRE). CREB 
was first implicated in drug-induced alterations in response to acute and chronic morphine 
treatment within the locus coeruleus, another brain region associated with addiction [50]. 
Later, it was found that chronic, but not acute, morphine caused a decrease in CREB within 
the NAc [51]. Cocaine self-administration was found to be sensitive to PKA inhibition, an 
upstream regulator of CREB, by increasing lever pressing [52]. Following this experiment, it 
was later found that NAc overexpression of CREB caused a decrease in cocaine-CPP behav-
ior [41]. Conversely, overexpression of a mutant CREB containing a single-point mutation, 
alanine for serine at residue 133, that  prevents its  phosphorylation and blocks its ability to 
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regulate transcription acting as a dominant negative form of CREB, caused an increase in 
cocaine-CPP behavior. Further correlating the role of this transcription factor in the associa-
tion of drug cues, researchers found that re-exposure to the original drug-paired environ-
ment in CPP without drug caused increased phosphorylation of CREB [53]. Highlighting 
the differences of behavioral tasks, it was found that NAc overexpression of CREB caused 
an increase in self-administration behavior [54]. This gene has also been studied in human 
patients. Researchers found that opioid-dependent patients were more likely to have a poly-
morphism in a protein that associates with CREB, CREB-binding protein, within a region 
associated with its activation by phosphorylation [55]. Altogether, it appears that CREB 
expression is involved in many aspects of addiction-related behavior.
CREB is a nuclear transcription factor that binds to CRE upstream of target genes. CREB 
regulation has been found to cause upregulation of ARG mRNA such as c-fos, Fosb, brain-
derived neurotropic factor (BDNF), and TrkB (e.g., in methamphetamine self-administration 
[56]). BDNF and its receptor TrkB have a very long history in the study of addiction-related 
behaviors as well as general plasticity occurring within the brain [57]. Further implicating 
CREB as a regulator of plasticity, it has been found to be involved in late-phase forms of long-
term potentiation (LTP [58]). As mentioned before, NAc neurons are normally quiescent and 
require glutamate activation with or without dopamine stimulation to fire. CREB has been 
associated with the regulation of this feature of NAc neuronal membrane excitability [59]. 
It was found that increased CREB activity leads to enhanced NMDAR-mediated currents, 
an important receptor for causing action potentials as well as for learning and memory. This 
regulation increases NAc neuronal-firing probability through enhancement of the membrane 
excitability. This may partially explain the effect of NAc CREB on behaviors such as self-
administration. Thus, CREB regulates the expression of many genes associated with plasticity 
and addiction-related behaviors.
CREB and ∆FosB are very well-documented addiction-related transcription factors but, 
undoubtedly, there are many more transcriptional factors that alter addiction-related plastic-
ity and ultimately behavior. Myocyte-enhancing factor 2 (MEF2) was found to be involved 
in cocaine-induced structural plasticity [60]. Interestingly, it was necessary and sufficient to 
increase the number of dendritic spines. Structural plasticity or the alteration of the physi-
cal synaptic shape has been associated with electrophysiological measurements of plasticity 
[61–63]  specifically in addiction [63]. Additionally, it was found that MEF2 regulates a wide 
network of plasticity-associated genes opening up further exploration into its role in addic-
tion-related plasticity and behavior [64]. Overall, transcriptional regulation of ARG expres-
sion can lead to modifications in drug-evoked synaptic plasticity and behavior [65, 66].
3. Posttranscriptional regulation of plasticity and addiction-related 
transcripts can promote addiction-like behaviors
Posttranscriptional regulation occurs after transcription until the mRNA is translated into a 
functional protein. Posttranscriptional regulation takes many forms such as mRNA process-
ing, splicing, editing, stability, and translation. mRNA stability and translation have been 
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the most well-characterized posttranscriptional mechanism in plasticity, especially in addic-
tion. Additionally, it appears that mRNA stability may be especially important in the brain, 
as nearly 20% of brain-expressed genes have been predicted to be controlled through this 
mechanism [67].
3.1. miRNAs destabilize specific mRNAs which could lead to diminished expression of 
genes involved in addiction
Stability can be influenced by direct binding of factors to discrete recognition sites. One group 
of factors involved in this type of mRNA stability are small noncoding RNAs, termed microR-
NAs (miRNAs). miRNAs are ~20–22 oligonucleotide molecules that are encoded within the 
genome and make up nearly 2–3% of transcribed genes but are not translated into protein. 
miRNAs target specific mRNAs through binding of complementary sequences within the 
miRNA, termed seed regions, to the 3’ untranslated region (UTR) of the mRNA. Association 
of miRNAs with the 5’UTR of mRNA has also been discovered [68] leading to different 
 cellular effects, but most studies within the brain have focused on the 3’UTR. Accordingly, 
the rest of this section focuses on this mechanism.
Although the miRNA may associate directly with the mRNA target, the aftereffects of this 
binding are mediated through a large, supporting protein complex, the RNA-induced-
silencing complex or RISC. Through associating with the RISC, an miRNA can target specific 
mRNAs for degradation or translational repression [69]. This complex contains a multitude 
of auxiliary proteins, with the most important being Argonaute (Ago; [70]). Ago is the compo-
nent most directly involved in regulating the mRNA. There are many Ago isoforms, but gen-
erally they are separated into those containing nuclease “slicer” activity and those without. 
Thus, Ago is important for the well-characterized miRNA-induced destruction of mRNA.
Although one miRNA has one specific seed region to bind to mRNAs, mRNAs may have 
numerous sites complementary for multiple miRNAs. This suggests that a single miRNA tar-
gets many mRNAs, affecting a myriad of cellular processes and pathways. This is reminiscent 
of transcriptional regulation, as one transcription factor may regulate a specific sequence that 
is upstream of various types of genes. This opens the possibility for an miRNA that may regu-
late a network of plasticity-associated genes. For example, miR-9-3p was found to diminish 
Dmd and Sap97 mRNA [71]. These genes are negatively associated with LTP expression, thus 
miRNA-induced silencing of these mRNAs would reverse this effect. A hippocampal LTP-
dependent behavior, the Morris water maze, was also found to be regulated by the expression 
of this miRNA.
Similar to a group of plasticity- and addiction-associated transcription factors, miRNA 
expression patterns appear to be similar to IEGs in their temporal- and activity-dependent 
regulation [72–74]. As demonstrated before, many of these IEGs play integral roles in  general 
plasticity and addiction-related plasticity. Similar to IEGs, miRNAs have been associated 
with neural development, synaptic plasticity, and even behavior [73–79].
The role of miRNA-induced posttranscriptional regulation in addiction was first studied in the 
regulation of the large-conductance-calcium-and-voltage-activated potassium channel (BK). 
This channel is integral to plasticity by affecting excitability, firing, and transmitter release 
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from neurons [80]. It is also one of the many protein targets of alcohol within the brain, for the 
most part potentiating its conductance [81]. This channel has been well studied in its role 
in tolerance to alcohol in the striatum, requiring larger amounts to exert similar effects [82]. 
This seems to be mediated by decreased BK channel expression in the membrane. A single 
gene can produce multiple mRNAs with the same coding region but with different 3’UTRs 
through the inclusion or exclusion of different exons [83]. Research has shown that the alpha 
subunit of this BK channel is alternatively spliced both in the coding region and in the 3’ UTR 
in response to neuronal activity [82, 84]. These researchers also found that alcohol caused a 
decrease in one specific BK mRNA that has an miR-9-binding site in its 3’ UTR. Given that this 
isoform of the BK channel mRNA is the most abundant in the striatum and miR-9 expression 
is increased by alcohol exposure, alcohol tolerance seems to be mediated at least in part by 
this miRNA [82]. As mentioned before, miRNAs target many mRNAs that contain a comple-
mentary sequence in the 3’UTR. Thus, these authors also proposed that miR-9 targets many 
other mRNAs such as the beta subunit of the GABA receptor, GABRB2, and the D2 receptor. 
Overall, this suggests that alcohol-mediated upregulation of miR-9 leads to the development 
of an alcohol-specific regulation of mRNAs associated with plasticity and addiction.
When animals are given extended access to drugs of abuse in a self-administration model, 
they undergo a specific behavioral response termed escalation of drug use. Uncontrollable use 
of large amount of drugs is an important facet in the human condition. With this,  researchers 
sought out an miRNA that may be increased by this behavior and found that miR-212, 
an activity-dependent miRNA regulated by CREB, was upregulated in the dorsal striatum of 
these animals after extended access [85]. One of the targets of miR-212 is Sprout-related, EVH1 
domain containing 1 (SPRED1), a corepressor of serine-threonine protein kinase Raf1, which 
increases the activity of adenylate cyclase by promoting its phosphorylation. Thus, upregu-
lation of miR-212 during escalated drug use diminishes SPRED1 levels, potentiating cAMP 
production and CREB activity leading to increased miR-212 expression. When miR-212 was 
overexpressed within the dorsal striatum, rats in extended access showed decreased levels of 
cocaine infusions. Oppositely, blocking of miR-212 by a locked nucleic acid (LNA) caused an 
increase in cocaine infusions. Thus, extended access to cocaine may recruit miR-212 leading 
to a positive feedback loop that effectively diminishes stereotypical escalation of drug intake. 
Overall, this suggests miR-212 acts on a pathway involving CREB to enhance its signaling, 
possibly in a compensatory, protective manner.
3.2. RNA-binding proteins bind to mRNAs and can bidirectionally regulate addiction-
associated mRNA translation into protein
RNA-binding proteins (RBPs) are another group of regulators of mRNA stability and trans-
lation. Some RBPs recognize discrete sequences in the 3’UTR, such as the AU-rich instabil-
ity conferring elements (AREs [86]). As with miRNAs, there is potential for a single RBP to 
affect multiple downstream processes leading to miRNAs and RBPs to be termed “master 
switches” of gene regulation [87, 88]. This is especially important in the brain, as around 
15–20% of brain-specific transcripts contain AREs suggesting these genes are regulated by 
this type of posttranscriptional regulation [67]. Fragile x-mental retardation protein (FMRP) 
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is an RBP that regulates the translation of nearly 850 brain mRNAs, many associated with 
synaptic function [89]. One of its regulatory targets are the group I metabotropic glutamate 
receptors mGluR1 and mGluR5 [90–92]. These receptors have been associated with cocaine-
evoked behaviors [93, 94]. Thus, Smith and colleagues tested the role of FMRP in addiction-
related behaviors [95]. They found that Fmr1 KO mice were deficient in cocaine locomotor 
sensitization and conditioned place preference. The effect on conditioned place preference 
was reversed by genetic reduction in mGluR5, suggesting that FMRPs effect on drug-evoked 
behaviors was due to mGluR5 activity. Finally, they found that FMRP caused a reduction in 
cocaine-induced structural plasticity suggesting that these behavioral deficits may be caused 
by this aberrant plasticity.
Although FMRP is the only RBP specifically studied in addiction-like behaviors, many more 
have been associated with these behaviors [96]. One such family of RBPs is the Hu, or embry-
onic lethal abnormal vision-like (ELAV-L) proteins. Hu proteins are brain and neuronal specific 
and are homologous to the Drosophila protein ELAV protein [97, 98]. HuD expression and func-
tion is activity dependent, suggesting it may regulate IEGs and other activity-dependent genes 
associated with plasticity [99–101]. In confirmation of this idea, our laboratory has shown that 
HuD is critical for stabilizing U-rich containing mRNAs during neuronal development and 
synaptic plasticity [101]; work from our laboratory reviewed in [102, 103]. HuD is a critical 
regulator of multiple plasticity-associated genes, thus suggesting that it may be involved in 
addiction-related altered gene expression, plasticity, and ultimately behavior. Overall, post-
transcriptional regulation may emerge as an important player tying drug-evoked molecular 
alterations with behavior.
3.3. mRNA editing can alter the sequence or expression of an addiction-related mRNA 
leading to alterations in addiction-related plasticity and behavior
mRNA editing is another posttranscriptional regulatory mechanism. The most common 
mechanism for RNA editing is through covalent modifications of a specific nucleotide, with-
out the alteration of the original DNA-encoded gene. This would generate multiple alterna-
tive forms of a protein which may be important in different cellular contexts.
The most common mRNA modification leading to editing is the removal of an amino group 
and its replacement with an oxygen, termed deamination. This occurs on the N6 position 
of adenosine nucleotides, converting this nucleotide into an inosine. This position directly 
contributes to conventional Watson-Crick base pairing, thus allowing inosine to pair with 
cytosine similar to guanosine. Translationally, this leads to the original adenosine to be read 
as a guanine, effectively causing an A→G site-directed mutagenesis. This modification is cata-
lyzed by adenosine deaminase that acts on RNA (ADAR) enzymes [104–108].
Specific mRNA editing in a neurophysiological context was first described in the GluRA2 
subunit of AMPAR [109]. As mentioned before, editing of mRNA is a rapid mechanism 
to generate multiple alternative forms of a protein depending on environmental circum-
stances. These receptors are integral to excitatory synaptic signaling, especially in plastic-
ity. Thus, AMPAR editing generates channels that are impermeable to calcium and displays 
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faster recovery rates from desensitization. In terms of drug-induced plasticity, a recent 
study  demonstrated that GluA2 editing by ADAR2 in the NAc of rats regulates cocaine 
seeking [110]. These researchers studied reinstatement, a specific stage of drug self-admin-
istration [36]. Animals first need to learn the required instrumental behavior to receive a 
reward in self-administration. When the animal reaches an experimenter-determined crite-
rion, then the animal is said to have “acquired” self-administration behavior. If the animal 
is then presented with the same context and levers, but rewards are withdrawn, the animal 
will eventually override the previously learned reward-driven behavior. Eventually, the ani-
mal will no longer perform the task required for the reward, which is termed extinction. 
Finally, when an animal is exposed to cues associated with the reward or the reward itself, 
the animal will reinstate its behavior to receive the reward. Reinstatement is thought to be 
analogous to relapse in human-addiction patients. In this study, they found that abstinence 
from cocaine was associated with a decrease in NAc-edited calcium-impermeable AMPAR 
as well as ADAR2. Next, Schmidt and colleagues overexpressed ADAR2 within the NAc. 
They found that this diminished cocaine-primed reinstatement of self-administration behav-
ior, suggesting that ADAR2 within the NAc is important for the regulation of relapse-like 
behavior. Overall, there are many avenues for mRNA editing in drug-induced plasticity and 
addiction-like behaviors [111].
Another posttranscriptional mRNA modification is the covalent modification of adenosine to 
N6-methyladenosine (m6A). This modification is carried out by a methyltransferase complex, 
containing WTAP, METTL14, and KIAA1429. Hence, this complex is usually thought of as the 
“writers” of m6A modifications. In opposition to the activity of this complex, enzymes have 
been discovered that promote the demethylation of mRNA, or the “erasers” of these modifi-
cations. These modifications have been studied for many years as a stable, unalterable modi-
fication. However, with the discovery of m6A demethylases this shifted opinion to suggest 
that this modification is dynamic and thus could be regulated by physiological conditions 
(reviewed in [112]). For example, it was reported that regulation of m6A was important to the 
normal functioning of the circadian rhythm in mammals [113]. Thus, m6A is physiologically 
relevant in behavior.
The first m6A demethylase to be discovered was the fat mass and obesity-associated protein 
(FTO). As the name suggests, it was identified as the strongest genetic variation to predispose 
patients to obesity [114–117]. At the opening of this chapter, evidence was presented to show 
that addiction-related neurocircuitry originally evolved to elicit goal-directed behavior toward 
food, suggesting this gene may also be involved in other forms of goal-directed behavior. The 
first study to link these findings was performed in alcoholic patients, finding that the genotype 
associated with obesity (rs9939609) was inversely correlated with general alcohol consump-
tion, measures of alcohol dependence, as well as cigarette use [118].
Later work found that this gene is expressed in dopaminergic neurons within the midbrain 
and is increased by acute cocaine administration (20 mg/kg [119]). Cocaine, and to a lesser 
extent amphetamines, inhibits the dopamine transporter (DAT), leading to increased synaptic 
dopamine. This in turn leads to hyperactivation of dopamine receptors on both sides of the 
synapse. The presynaptic terminal contains D2 and D3 receptors, which are inhibitory GPCRs. 
Thus, the presynaptic dopaminergic neuron will show increased suppression of firing in 
response to cocaine. In the next set of experiments, these researchers found that Fto-deficient 
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dopaminergic neurons showed diminished cocaine-induced suppression of firing rate, sug-
gesting that signaling through D2/D3 receptors is regulated by Fto. As expected, it was found 
that protein expression of these downstream targets (DRD3, GIRK2, and NMDAR1) was 
reduced by Fto deficiency. Functionally, Fto deficiency led to a reduction in GIRK currents, 
possibly detailing a mechanism for the diminished cocaine-induced suppression of firing 
rate in dopaminergic neurons. Finally, Fto-deficient mice showed attenuated acute cocaine-
induced locomotor activity, suggesting that these genetic and electrophysiological measures 
translate into this behavioral modification.
4. Conclusion
As shown here, there are many avenues for regulation of ARGs at the transcriptional or the 
posttranscriptional level. These regulatory mechanisms all have been implicated in the devel-
opment of this disorder and thus may be involved in the vulnerability of some individuals to 
substance-use disorders. Understanding the regulation of addiction-related genes and their 
impact on synaptic plasticity and behavior may inform new pharmacological treatments that 
reverse these aberrant drug-evoked forms of plasticity in favor of remission.
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